The new version of the medical insurance catalog of "medical headlines" starts to implement the second batch of key points of volume purchase

(2020 / 01 / 02) the new version of the medical insurance catalogue has been implemented on January 1 97 negotiated drugs have officially entered the medical insurance; the key points of the second batch of national on-line procurement have been sorted out; it is in line with the international "detailed rules for the preparation of national pharmaceutical excipients standards" and published in 2019; the 2020 R & D pipeline report: which areas deserve attention These enterprises can give some inspiration to the industry This quotation is the same as 4 + 7 and the expansion of combined mining, and still belongs to one price It is very important to construct the pharmacopoeia standard system of Chinese pharmaceutical excipients scientifically What's the change in the new round? These four principles are very important for us to ensure that our products stand out in the competition 2020 has come! At the beginning of the new decade, what are our expectations for the era of Biomedical Innovation? These drugs are identified as one vote varieties Headline bacteria: from January 1, 2019 version of the national medical insurance catalogue will be implemented soon, and a large number of varieties will face challenges.